tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gavin Clark-Gartner, 75 are a BUY (94.94%), 4 are a HOLD (5.06%).
Analyst Gavin Clark-Gartner, currently employed at EVERCORE, carries an average stock price target met ratio of 43.15% that have a potential upside of 46.55% achieved within 87 days.
Gavin Clark-Gartner’s has documented 158 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR.
Analyst best performing recommendations are on LBPH (LONGBOARD PHARMACEUTICALS).
The best stock recommendation documented was for LBPH (LONGBOARD PHARMACEUTICALS) at 12/22/2023. The price target of $25 was fulfilled within 11 days with a profit of $19 (316.67%) receiving and performance score of 287.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2026
$325
$39.36 (13.78%)
$300
7 days ago
(21-Oct-2026)
1/3 (33.33%)
$40.2 (14.12%)
231
Buy Since 05-Feb-2020
$288
$2.36 (0.83%)
$288
19 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 07-Jan-2026
$275
$-10.64 (-3.72%)
$260
19 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$14.36 (5.03%)
$280
20 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 16-Nov-2023
$290
$4.36 (1.53%)
$285
20 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
Which stock is Gavin Clark-Gartner most bullish on?
Which stock is Gavin Clark-Gartner most reserved on?
What Year was the first public recommendation made by Gavin Clark-Gartner?
